HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sulma I Mohammed Selected Research

Cyclooxygenase Inhibitors

4/2007Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
2/2006Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects.
2/2003Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
1/2002Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sulma I Mohammed Research Topics

Disease

26Neoplasms (Cancer)
01/2022 - 01/2002
8Urinary Bladder Neoplasms (Bladder Cancer)
05/2010 - 01/2002
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2006
4Breast Neoplasms (Breast Cancer)
01/2019 - 11/2005
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 01/2009
3Transitional Cell Carcinoma
05/2010 - 01/2002
3Carcinoma (Carcinomatosis)
01/2008 - 01/2006
2Hypoxia (Hypoxemia)
12/2015 - 12/2015
1COVID-19
01/2022
1Malnutrition (Nutritional Deficiencies)
01/2022
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Acute-Phase Reaction
01/2020
1Lymphatic Metastasis
01/2019
1Circulating Neoplastic Cells
01/2019
1Obesity
01/2019
1Triple Negative Breast Neoplasms
02/2018
1Fibrosis (Cirrhosis)
12/2015
1Inflammation (Inflammations)
12/2015
1Necrosis
12/2015
1Acidosis
12/2015
1Genomic Instability
12/2015
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
12/2015
1Carcinogenesis
12/2015
1Ovarian Neoplasms (Ovarian Cancer)
03/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2010

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2006
5Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
4Piroxicam (Feldene)FDA LinkGeneric
04/2007 - 01/2002
4Cyclooxygenase InhibitorsIBA
04/2007 - 01/2002
3Hormones (Hormone)IBA
12/2015 - 06/2008
3PhytochemicalsIBA
12/2015 - 12/2015
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2010 - 01/2002
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 12/2015
2Cadherins (E-Cadherin)IBA
01/2020 - 01/2006
2CholesterolIBA
01/2019 - 12/2015
2Phenobarbital (Luminal)FDA Link
01/2019 - 02/2018
2Biological ProductsIBA
12/2015 - 01/2008
2Drug CombinationsIBA
12/2015 - 12/2015
2CurcuminIBA
12/2015 - 01/2009
2ResveratrolIBA
12/2015 - 12/2015
2Telomerase (Telomerase Reverse Transcriptase)IBA
12/2015 - 12/2015
2LigandsIBA
01/2006 - 11/2005
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2003 - 01/2002
2ProstaglandinsIBA
02/2003 - 01/2002
1biliverdin reductaseIBA
01/2020
1Phosphopyruvate Hydratase (Enolase)IBA
01/2020
1Kininogens (Kininogen)IBA
01/2020
1Valosin Containing ProteinIBA
04/2016
1naringeninIBA
12/2015
1Carotenoids (Carotene)IBA
12/2015
1BerberineIBA
12/2015
1Oxygen (Dioxygen)IBA
12/2015
1EndoglinIBA
12/2015
1Polysaccharides (Glycans)IBA
12/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2015
1onionin AIBA
12/2015
1SeleniumIBA
12/2015
13,5-dihydroxy-4'-methoxystilbeneIBA
12/2015
1Vitamin DFDA LinkGeneric
12/2015
1zerumboneIBA
12/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2015
1IsothiocyanatesIBA
12/2015
1Interleukin-12 (IL 12)IBA
12/2015
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2015
1GenisteinIBA
12/2015
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
12/2015
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2015
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
12/2015
1Janus KinasesIBA
12/2015
1piperineIBA
12/2015
1Paclitaxel (Taxol)FDA LinkGeneric
03/2012
1HydrogelsIBA
03/2012
1Hyaluronic Acid (Hyaluronan)IBA
03/2012
1Pharmaceutical PreparationsIBA
03/2012
1Antineoplastic Agents (Antineoplastics)IBA
12/2010
1Cyclin-Dependent Kinase Inhibitor p16IBA
12/2010
1indole-3-carbinolIBA
12/2010
1GemcitabineFDA Link
12/2010
1Celecoxib (Celebrex)FDA Link
05/2010
1Progesterone Receptors (Progesterone Receptor)IBA
04/2010
1Hematoxylin (Haematoxylon)IBA
04/2010
1Eosine Yellowish-(YS) (Eosin)IBA
04/2010
1human ERBB2 proteinIBA
04/2010
1Estrogen ReceptorsIBA
04/2010
1GoldIBA
09/2008
1AntigensIBA
06/2008
1LeptinIBA
06/2008
1CollagenIBA
06/2008
1CortactinIBA
06/2008
1Protein Isoforms (Isoforms)IBA
06/2008
1cytotropic heterogeneous molecular lipid (CHML)IBA
01/2008

Therapy/Procedure

12Therapeutics
11/2020 - 01/2006
3Drug Therapy (Chemotherapy)
12/2015 - 02/2003
2Radiotherapy
01/2022 - 12/2015
1Palliative Care (Palliative Therapy)
01/2022
1Tertiary Prevention
11/2020
1Castration
01/2020
1Cystectomy
05/2010